## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `retatrutide-corticosteroids`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/retatrutide-corticosteroids/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-corticosteroids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-corticosteroids/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/retatrutide-corticosteroids/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-corticosteroids/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/retatrutide-corticosteroids/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `retatrutide-corticosteroids` v2 · content_hash `bbc83ddaffea58a2…` · thread_head genesis · 24 DIVs
- **thesis (c1):** Phase 2 trial showed 24.2% mean weight loss at 48 weeks with 12 mg retatrutide vs 2.1% placebo in adults with obesity.
  - c2 [human/active] Phase 3 data: 12 mg retatrutide produced 28.3% average weight loss over 80 weeks; 45.3% reached ≥30% loss.
  - c3 [human/active] Local corticosteroid injections (low dose, targeted) do not typically cause systemic weight gain unlike long-term oral steroids.
  - c4 [human/active] Repeated local corticosteroid injections associate with tissue weakening and atrophy.
  - c5 [preclinical/active] Observational data suggest GLP-1 receptor agonists may blunt some metabolic effects of steroids.
  - c6 [anecdotal/active] Reddit users report 8–30 lb losses on retatrutide with appetite suppression.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/retatrutide-corticosteroids/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/retatrutide-corticosteroids/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `retatrutide-corticosteroids`
- **title:** Retatrutide and Corticosteroid Injections: Evidence on Weight-Related Load and Tissue Effects
- **url:** https://miscsubjects.com/a/retatrutide-corticosteroids
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:15.920Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Corticosteroid injections deliver strong local anti-inflammatory effects. Repeated use in the same area links to weakening of tendons, cartilage, and surrounding tissue in some reports. Systemic corticosteroids, especially oral forms taken long-term, often increase appetite and promote fat storage, raising body weight. Extra body weight multiplies compressive forces on joints, spine, and soft tissues—roughly 4 pounds of additional load per pound gained in the lumbar spine during standing activities.

Retatrutide targets a different layer: metabolic load from excess weight. The focus here stays on whether reducing that load through studied weight-loss pathways could offset one contributor to ongoing tissue stress when corticosteroids are part of the picture.

## Why Retatrutide might help you

1. What keeps failing: Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.
2. What Retatrutide is studied to do: Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.
3. Therefore for you: If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

## Why Corticosteroid injections matters for you

1. Drug: Corticosteroid injections
2. What it does: Powerful anti-inflammatory; repeated use linked to tissue weakening.
3. Therefore for you: This drug suppresses a signal (inflammation) and can provide short-term relief, but it trades off potential repair by weakening local tissues with repeated exposure. It does not reduce mechanical load from body weight and may indirectly increase it if appetite rises with systemic exposure.

## How these fit together

Single-compound focus — Retatrutide targets metabolic load / body weight. Corticosteroid injections address inflammatory signaling with the noted trade-off on tissue integrity. No direct synergy data exists for the pair; any combined use would require separate monitoring of weight trajectory and local tissue response.

## What the evidence actually shows

Human phase 2 trial (NEJM 2023): 338 adults with obesity received retatrutide up to 12 mg weekly. At 48 weeks the 12 mg group showed mean weight reduction of 24.2 % versus 2.1 % on placebo. Over 80 % of participants on 12 mg lost at least 15 % body weight. Gastrointestinal side effects were most common and dose-related.

Phase 3 topline data (2026): Participants on 12 mg lost average 28.3 % body weight (70.3 lbs) over 80 weeks; 45.3 % reached ≥30 % loss. Extension to 104 weeks in severe obesity subgroup reached 30.3 % mean loss.

Corticosteroid data: Local injections (10–40 mg) show minimal systemic weight gain in short courses. Long-term oral corticosteroids link to 4–8 % weight gain over two years in rheumatoid arthritis cohorts. Repeated local injections associate with tissue atrophy and cartilage thinning in observational reports.

GLP-1 class: Limited observational data suggest potential to blunt steroid-induced metabolic shifts (weight gain, hyperglycemia); no retatrutide-specific trials in steroid users.

## What scientists say

Phase 2 and 3 investigators note substantial weight reduction with retatrutide but highlight need for longer cardiovascular outcome trials. No published statements address retatrutide specifically alongside corticosteroid injections.

## What people say on Reddit

Anecdotal reports describe appetite suppression and 8–30 lb losses in first weeks to months on retatrutide (various doses). Type 1 diabetes users note variable blood-glucose effects due to glucagon activity. No posts specifically link retatrutide use to corticosteroid injections.

## What people say on X

Public posts on retatrutide remain sparse and focus on trial results or general weight-loss expectations. No verified user reports tying retatrutide to corticosteroid contexts appear in indexed searches.

## What we do not know

No human trials examine retatrutide in patients receiving corticosteroid injections. Direct effects on tendon or joint tissue repair remain unstudied. Long-term safety beyond 104 weeks is unknown. Interaction profile with injected corticosteroids lacks dedicated data.

## Safety and limits

Retatrutide remains investigational; not FDA-approved. Common effects in trials include nausea, diarrhea, vomiting (dose-dependent, often during escalation). Heart-rate increases observed early then declined. Corticosteroid risks include local tissue weakening with repetition and, for systemic forms, broader metabolic changes. All claims here rest on existing trial or observational data; individual responses vary.

## Claims (6)

- **c4** [human w=0.8] Repeated local corticosteroid injections associate with tissue weakening and atrophy.
  - who_claims: grok/grok-4.3
  - sources: s4
- **c5** [preclinical w=0.5] Observational data suggest GLP-1 receptor agonists may blunt some metabolic effects of steroids.
  - who_claims: grok/grok-4.3
  - sources: s5
- **c1** [human w=0.8] Phase 2 trial showed 24.2% mean weight loss at 48 weeks with 12 mg retatrutide vs 2.1% placebo in adults with obesity.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [human w=0.8] Phase 3 data: 12 mg retatrutide produced 28.3% average weight loss over 80 weeks; 45.3% reached ≥30% loss.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c3** [human w=0.8] Local corticosteroid injections (low dose, targeted) do not typically cause systemic weight gain unlike long-term oral steroids.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c6** [anecdotal w=0.3] Reddit users report 8–30 lb losses on retatrutide with appetite suppression.
  - who_claims: grok/grok-4.3
  - sources: s6

## Voxel graph (6 atoms · 12 edges)
- full graph: https://miscsubjects.com/api/articles/retatrutide-corticosteroids/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (6)
- chain valid: yes · head: `a3e8890a10f13805`

### s1 · pubmed · http_403
- title: Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
- url: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
- summary: Phase 2 human trial results on weight loss.
- quote: At 48 weeks, the least-squares mean percentage change in the retatrutide groups was −8.7% in the 1-mg group, −17.1% in the combined 4-mg group, −22.8% in the combined 8-mg group, and −24.2% in the 12-mg group, as compared with −2.1% in the placebo group.
- claim_ids: c1
- hash: `ca77cb7b165fc11d`

### s2 · news · ok
- title: Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
- url: https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss
- summary: Phase 3 topline weight-loss data.
- quote: participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3 %) over 80 weeks with 45.3% of participants achieving ≥30% weight loss
- claim_ids: c2
- hash: `32a04e78bb30f3bc`

### s3 · medical · ok
- title: Do steroid injections make you put on weight?
- url: https://www.ultrasound-guided-injections.co.uk/do-steroid-injections-make-you-put-on-weight/
- summary: Distinguishes injection vs oral steroid weight effects.
- quote: Steroid injections do not make you put on weight. However, weight gain can be associated with long-term oral (tablet) steroid use.
- claim_ids: c3
- hash: `b07fff53d40457c0`

### s4 · medical · ok
- title: Pros and Cons of Cortisone Shots
- url: https://www.commonspirit.org/blog/pros-and-cons-of-cortisone-shots
- summary: Tissue risk of repeated injections.
- quote: Long-term, repeated administration of cortisone shots can be particularly problematic, as frequent injections in the same joint can damage it, as well as the surrounding soft tissue.
- claim_ids: c4
- hash: `bb268a574abf59e4`

### s5 · pubmed · ok
- title: Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes and hyperglycemia
- url: https://www.frontiersin.org/journals/clinical-diabetes-and-healthcare/articles/10.3389/fcdhc.2026.1772391/full
- summary: Observational/preclinical suggestion for GLP-1 class.
- quote: glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may have therapeutic potential to counteract the metabolic effects of steroids.
- claim_ids: c5
- hash: `4eb129ed010ec532`

### s6 · reddit · ok
- title: has anyone tried retatrutide and what were the effects
- url: https://www.reddit.com/r/diabetes_t1/comments/1rlv501/has_anyone_tried_retatrutide_and_what_were_the/
- summary: User-reported weight loss and effects.
- quote: lost around 8 kg in 4 weeks with 2mg alone... I’ve seen other t1d take Reta...
- claim_ids: c6
- hash: `a3e8890a10f13805`

## Provenance (2 model passes)
- chain valid: yes · head: `3f4927a1c777e1d6`

- write · grok/grok-4.3 · 2026-06-30T01:02 · hash `4543d3a77599`
- voxel_divide · owner · 2026-07-17T02:41 · hash `3f4927a1c777`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/retatrutide-corticosteroids/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/retatrutide-corticosteroids/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"retatrutide-corticosteroids","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest retatrutide-corticosteroids|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim retatrutide-corticosteroids|tier|assertion`
- **iMessage ask:** `retatrutide-corticosteroids|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `retatrutide-corticosteroids`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-corticosteroids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-corticosteroids/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*